Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference

Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference

YEAR IN REVIEW Advanced breast cancerПодробнее

YEAR IN REVIEW Advanced breast cancer

Adjuvant Therapy | 2023 KU Breast Cancer Year in Review ConferenceПодробнее

Adjuvant Therapy | 2023 KU Breast Cancer Year in Review Conference

HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review ConferenceПодробнее

HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review Conference

Antibody-Drug Conjugates for HER2-Low Disease: 2023 KU Breast Cancer Year in ReviewПодробнее

Antibody-Drug Conjugates for HER2-Low Disease: 2023 KU Breast Cancer Year in Review

Historical Perspective on HR+/HER2- Breast Cancer: 2023 KU Breast Cancer Year in ReviewПодробнее

Historical Perspective on HR+/HER2- Breast Cancer: 2023 KU Breast Cancer Year in Review

2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic TherapyПодробнее

2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic Therapy

2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment ApproachesПодробнее

2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment Approaches